-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[ Focus on Chemical Machinery Equipment Network ] The end of the year is coming, and the investment situation of various industries this year has gradually surfaced, which is attracting great attention from people in various industries
.
According to data recently released by the National Bureau of Statistics, from January to November, the national investment in fixed assets (excluding rural households) was 4,94082 trillion yuan, a year-on-year increase of 5.
2%
.
Chemical machinery and equipment network hotspots pay attention to chemical machinery and equipment.
According to data recently released by the National Bureau of Statistics, from January to November, the national investment in fixed assets (excluding rural households) was 4,94082 trillion yuan, a year-on-year increase of 5.
2%
.
In terms of industries, in the first 11 months, investment in special equipment manufacturing increased by 25.
3% year-on-year, followed by electrical machinery and equipment manufacturing, railway, shipbuilding, aerospace and other transportation equipment manufacturing, computer, communications and other industries.
The investment in electronic equipment manufacturing, health and social work increased by 24.
4%, 23.
1%, 21.
4%, and 21.
3% respectively year-on-year.
In addition, the pharmaceutical manufacturing, general equipment manufacturing, manufacturing and other industries with investment increased by more than 10% year-on-year
.
3% year-on-year, followed by electrical machinery and equipment manufacturing, railway, shipbuilding, aerospace and other transportation equipment manufacturing, computer, communications and other industries.
The investment in electronic equipment manufacturing, health and social work increased by 24.
4%, 23.
1%, 21.
4%, and 21.
3% respectively year-on-year.
In addition, the pharmaceutical manufacturing, general equipment manufacturing, manufacturing and other industries with investment increased by more than 10% year-on-year
.
The investment in the pharmaceutical manufacturing industry in the first 11 months of this year increased by 11.
7% year-on-year, still maintaining a relatively high growth trend
.
For the whole year of 2020, the year-on-year growth rate of investment in industries above designated size in the pharmaceutical manufacturing industry will be 28.
4%
.
With sustained and stable investment, the transcripts handed over by the pharmaceutical manufacturing industry have not disappointed
.
According to statistics, as of September 2021, the pharmaceutical manufacturing industry has achieved a cumulative operating income of 2,129.
1 billion yuan, a year-on-year increase of 24.
4%; a cumulative total profit of 4,525.
3 billion yuan, a year-on-year increase of 80.
6%
.
It can be seen that the overall trend of the pharmaceutical manufacturing industry is stable, and the profit side is growing faster than the income side
.
7% year-on-year, still maintaining a relatively high growth trend
.
For the whole year of 2020, the year-on-year growth rate of investment in industries above designated size in the pharmaceutical manufacturing industry will be 28.
4%
.
With sustained and stable investment, the transcripts handed over by the pharmaceutical manufacturing industry have not disappointed
.
According to statistics, as of September 2021, the pharmaceutical manufacturing industry has achieved a cumulative operating income of 2,129.
1 billion yuan, a year-on-year increase of 24.
4%; a cumulative total profit of 4,525.
3 billion yuan, a year-on-year increase of 80.
6%
.
It can be seen that the overall trend of the pharmaceutical manufacturing industry is stable, and the profit side is growing faster than the income side
.
The pharmaceutical equipment industry is the upstream of the pharmaceutical industry and can be divided into general equipment and special equipment
.
Judging from the newly released data, from January to November this year, the investment in the general equipment manufacturing industry and the special equipment manufacturing industry also maintained rapid growth, with year-on-year growth rates of 11.
4% and 25.
3% respectively
.
.
Judging from the newly released data, from January to November this year, the investment in the general equipment manufacturing industry and the special equipment manufacturing industry also maintained rapid growth, with year-on-year growth rates of 11.
4% and 25.
3% respectively
.
Taking a closer look at the pharmaceutical equipment industry, since 2021, the biopharmaceutical industry has maintained a high boom, which has driven the growth of demand for biopharmaceutical-related equipment and consumables, and has a broad market prospect
.
In this context, many pharmaceutical machinery companies are actively deploying the biomedical sector through investment and cooperation
.
.
In this context, many pharmaceutical machinery companies are actively deploying the biomedical sector through investment and cooperation
.
For example, Chutian Technology introduced relevant technical talents in the field of disposable consumables this year, and established a holding company, Chutian Siyoute, to expand production capacity; in September, Chutian Technology announced that it plans to jointly fund the establishment of Chutian Microspheres with related parties.
Engaged in the business of providing microspheres and filler media
.
The purpose of this investment is to further supplement the biopharmaceutical-related equipment and product chain, realize the company's "one vertical, one horizontal, one platform" development strategy, enhance the company's overall competitiveness, and promote the company's development from an "equipment-based" enterprise to a "technology-based" enterprise; On December 8, Chutian reported that it would participate in the establishment of Changsha Bilian Chutian Company to further enrich the supply chain ecology and help expand the field of precision manufacturing
.
Judging from the company’s motives for increasing its layout, Chutian Technology once mentioned in a research report that the growth of biopharmaceuticals will drive the company’s business growth, and the proportion of the bioengineering sector will increase in the future
.
Engaged in the business of providing microspheres and filler media
.
The purpose of this investment is to further supplement the biopharmaceutical-related equipment and product chain, realize the company's "one vertical, one horizontal, one platform" development strategy, enhance the company's overall competitiveness, and promote the company's development from an "equipment-based" enterprise to a "technology-based" enterprise; On December 8, Chutian reported that it would participate in the establishment of Changsha Bilian Chutian Company to further enrich the supply chain ecology and help expand the field of precision manufacturing
.
Judging from the company’s motives for increasing its layout, Chutian Technology once mentioned in a research report that the growth of biopharmaceuticals will drive the company’s business growth, and the proportion of the bioengineering sector will increase in the future
.
For another example, Tofflon's pharmaceutical equipment sector is also pursuing diversified development
.
At the end of 2020, the company invested 500 million yuan to expand the production capacity of biological equipment.
On November 13 this year, Tofflon announced the "marriage" with Jiabei Pharmaceutical.
Cooperate in construction and other aspects to jointly build a biopharmaceutical platform
.
.
At the end of 2020, the company invested 500 million yuan to expand the production capacity of biological equipment.
On November 13 this year, Tofflon announced the "marriage" with Jiabei Pharmaceutical.
Cooperate in construction and other aspects to jointly build a biopharmaceutical platform
.
Benefiting from the overweight of capital, as well as multiple resonances such as the influx of talents, policy support, and market demand growth, the pharmaceutical equipment industry will perform well in 2021
.
In the first three quarters of this year, many pharmaceutical machinery companies have doubled their performance.
A representative example is Chutian Technology.
In the first three quarters of this year, the company's operating income and operating costs have increased significantly when new orders and in-hand orders have increased significantly.
Both achieved high growth, among which net profit was twice as much as the full-year net profit in 2020, and revenue increased by 57.
9% year-on-year
.
The industry also predicts that the company's performance in the fourth quarter and subsequent quarters is expected to maintain high growth; Tofflon will be attributable to shareholders of listed companies in the first three quarters of 2021 as new products and new markets in various business segments gradually show results.
Net profit increased by 93.
69% year-on-year, which also nearly doubled
.
.
In the first three quarters of this year, many pharmaceutical machinery companies have doubled their performance.
A representative example is Chutian Technology.
In the first three quarters of this year, the company's operating income and operating costs have increased significantly when new orders and in-hand orders have increased significantly.
Both achieved high growth, among which net profit was twice as much as the full-year net profit in 2020, and revenue increased by 57.
9% year-on-year
.
The industry also predicts that the company's performance in the fourth quarter and subsequent quarters is expected to maintain high growth; Tofflon will be attributable to shareholders of listed companies in the first three quarters of 2021 as new products and new markets in various business segments gradually show results.
Net profit increased by 93.
69% year-on-year, which also nearly doubled
.
Looking forward to 2022, the industry expects that the boom of the pharmaceutical manufacturing industry will continue to be maintained, investment is also expected to maintain steady growth, the pharmaceutical equipment industry will continue to benefit, and high-end, international, and innovative development will become the development direction of pharmaceutical machinery companies
.
At present, the scale of China's pharmaceutical equipment market has approached the 100 billion yuan mark, and is expected to reach 200 billion yuan by 2025
.
.
At present, the scale of China's pharmaceutical equipment market has approached the 100 billion yuan mark, and is expected to reach 200 billion yuan by 2025
.
Original title: The investment performance of the pharmaceutical manufacturing industry is still outstanding, with an increase of 11.
7% in the first 11 months
7% in the first 11 months
